NYSEAMERICAN:APHB

Ampliphi Biosciences - APHB Stock Forecast, Price & News

$0.32

-0.08 (-20.00%)

(As of 05/9/2019)

Add

Compare

Today's Range: $0.31
▼
$0.36
50-Day Range: N/A
52-Week Range: $0.15
▼
$1.37

Volume: 4.65 million shs
Average Volume: 842,200 shs
Market Capitalization: $10.71 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Ampliphi Biosciences (NYSEAMERICAN:APHB) Stock

AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company is involved in developing AB-SA01 for the treatment of staphylococcus aureus (S. aureus) infections; and AB-PA01 for the treatment of pseudomonas aeruginosa (P. aeruginosa) infections. It holds collaborative research and development agreements with the United States Army Medical Research and Materiel Command for the development of bacteriophage therapeutics to treat S. aureus, E. coli, and P. aeruginosa infections; and Walter Reed Army Institute of Research. The company was formerly known as Targeted Genetics Corporation and changed its name to AmpliPhi Biosciences Corporation in February 2011. AmpliPhi Biosciences Corporation was founded in 1989 and is headquartered in San Diego, California.

Receive APHB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ampliphi Biosciences and its competitors with MarketBeat's FREE daily newsletter.

APHB Stock News Headlines

October 27, 2021 | finance.yahoo.com

APHB: Case Study on AB-PA01 Presented at ISHLT Annual Meeting

April 30, 2020 | www.bloomberg.com

Lifshitz & Miller LLP Announces Investigation of AmpliPhi Biosciences Corporation, Churchill Capital Corporation, DaVita Inc.,

May 9, 2019 | finance.yahoo.com

C3J Therapeutics and AmpliPhi Biosciences Announce Successful Completion of Merger and Formation of Bacteriophage Company Armata Pharmaceuticals, Inc.

May 8, 2019 | finance.yahoo.com

AmpliPhi Biosciences Announces Stockholder Approval of Business Combination with C3J Therapeutics

April 2, 2019 | www.businesswire.com

C3J Therapeutics Announces Issuance of U.S. Patent Covering Synthetic Bacteriophage

March 27, 2019 | finance.yahoo.com

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of AmpliPhi Biosciences Corporation - APHB

March 18, 2019 | www.nasdaq.com

AmpliPhi Biosciences Corporation Estimate Momentum

January 15, 2019 | seekingalpha.com

AmpliPhi Biosciences Corp. (APHB) CEO Paul Grint on C3J Therapeutics Merger Conference Call (Transcript)

January 4, 2019 | www.bizjournals.com

AmpliPhi Biosciences and C3J Therapeutics Agree to Merge

January 4, 2019 | seekingalpha.com

AmpliPhi Bio up 45% premarket on merger with C3J Therapeutics

December 18, 2018 | seekingalpha.com

AmpliPhi Biosciences optimizes manufacturing process and scale up for AB-SA01

December 18, 2018 | finance.yahoo.com

AmpliPhi Biosciences Successfully Optimizes Manufacturing Process and Scale Up for AB-SA01 Clinical Development

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive APHB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ampliphi Biosciences and its competitors with MarketBeat's FREE daily newsletter.

APHB Company Calendar

Last Earnings: 3/25/2019
Today: 8/08/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSEAMERICAN
Industry: Biotechnology
Sub-Industry: N/A
Sector: Medical
Current Symbol: NYSEAMERICAN:APHB
Previous Symbol: AMEX:APHB
CUSIP: N/A
CIK: 921114
Web: www.ampliphibio.com
Phone: +1-804-8272524
Fax: N/A
Employees: 30
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 33,469,000
Free Float: N/A
Market Cap: $10.71 million
Optionable: Not Optionable
Beta: N/A

Key Executives

Dr. Paul C. Grint (Age 61)
CEO & Director
Mr. Steven R. Martin (Age 58)
Sr. VP & CFO
Mr. Michael Scott Salka (Age 57)
Consultant

Key Competitors

View All Competitors

APHB Stock - Frequently Asked Questions

How were Ampliphi Biosciences' earnings last quarter?: Ampliphi Biosciences Corp (NYSEAMERICAN:APHB) posted its quarterly earnings data on Monday, March, 25th. The biotechnology company reported ($0.15) EPS for the quarter, missing analysts' consensus estimates of ($0.08) by $0.07.
What other stocks do shareholders of Ampliphi Biosciences own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Ampliphi Biosciences investors own include Navios Maritime Partners (NMM), Sorrento Therapeutics (SRNE), Allena Pharmaceuticals (ALNA), Protalix BioTherapeutics (PLX), Synergy Pharmaceuticals (SGYP), AcelRx Pharmaceuticals (ACRX), Athersys (ATHX), Actinium Pharmaceuticals (ATNM), Anavex Life Sciences (AVXL) and Corbus Pharmaceuticals (CRBP).
What is Ampliphi Biosciences' stock symbol?: Ampliphi Biosciences trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "APHB."

How do I buy shares of Ampliphi Biosciences?: Shares of APHB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Ampliphi Biosciences' stock price today?: One share of APHB stock can currently be purchased for approximately $4.11.
How much money does Ampliphi Biosciences make?: Ampliphi Biosciences (NYSEAMERICAN:APHB) has a market capitalization of $137.56 million.
How many employees does Ampliphi Biosciences have?: Ampliphi Biosciences employs 30 workers across the globe.
How can I contact Ampliphi Biosciences?: Ampliphi Biosciences' mailing address is 3579 Valley Centre Drive, SAN DIEGO, CA 92130, United States. The official website for Ampliphi Biosciences is www.ampliphibio.com. The biotechnology company can be reached via phone at +1-804-8272524.

This page (NYSEAMERICAN:APHB) was last updated on 8/8/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MarketBeat Resources